| Target | CD194 |
|---|
| Application | ELISA, FA, FC |
|---|
| Clonality | Monoclonal |
|---|
| Conjugate | Horseradish Peroxidase (HRPO) |
|---|
| Isotype | Human IgG1κ |
|---|
| Immunogen | Humanization of mouse anti-CCR4 mAb7. |
|---|
| Species Reactivity | Human |
|---|
| Formulation | This HRP-conjugated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4, 1% BSA. (Warning: Use of sodium azide as a preservative will inhibit the enzyme activity of horseradish peroxidase) |
|---|
| Research Area | Cancer, Immunology |
|---|
| Description/Background | Clone KW-0761 (Mogamulizumab) is a research-grade, afucosylated, humanized monoclonal antibody generated from mouse anti-CCR4 mAb7 that targets human CCR4.1 CC chemokine receptor type 4 (CCR4) is a protein that belongs to the G protein-coupled receptor family and is a receptor for a variety of CC chemokines including MCP-1, MIP-1, RANTES, TARC, and Macrophage-derived chemokine. Chemokines are involved in the development, homeostasis, and function of the immune system and are known to regulate cell trafficking of various types of leukocytes. In a 2018 Phase I clinical trial, Mogamulizumab was found to decrease the number of HTLV-1–infected cells and the levels of inflammatory markers related to HTLV-1–Associated Myelopathy.3 |
|---|
| Storage Temperature | This horseradish peroxidase conjugated monoclonal antibody is stable when stored at 2-8°C. Do not freeze. |
|---|
| Protocols | ELISA, FA, FC |
|---|
| Clone Number | KW-0761 |
|---|
| Concentration | 0.5 mg/ml |
|---|
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
|---|
